๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

โœ Scribed by Huebner, G; Link, H; Kohne, C H; Stahl, M; Kretzschmar, A; Steinbach, S; Folprecht, G; Bernhard, H; Al-Batran, S E; Schoffski, P

Book ID
109999901
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
129 KB
Volume
100
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of carboplatin, gemcitabi
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site
โœ Bryan J. Schneider; Basil El-Rayes; Jeffery H. Muler; Philip A. Philip; Gregory ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP). ## METHODS. Patients with CUP received carboplatin AUC 5 mg/mL a minute intraven

Cisplatin and gemcitabine with either vi
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian Multicenter, randomized, phase II study
โœ Sergio Palmeri; Vito Lorusso; Laura Palmeri; Marina Vaglica; Camillo Porta; Rola ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND. To date, the standard treatment for patients who have carcinoma of unknown primary site has not been established. ## METHODS. In this randomized Phase II study, 66 previously untreated patients (33 patients per arm) with carcinomas of unknown primary site received cisp